Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
| Title | FOA | Organization | Release Date | Expire Date Sort ascending | Purpose |
|---|---|---|---|---|---|
| Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed) | RFA-RM-24-007 | RMOD | The purpose of this Notice Of Funding Opportunity (NOFO) is to solicit applications on the optimization and characterization of technologies and assays with the potential for utilization and adoption… More | ||
| Harnessing Artificial Intelligence and Polypharmacology to Discover Pharmacotherapeutics for Substance Use Disorders (R43/R44 Clinical Trials Not Allowed) | RFA-DA-25-054 | NIDA | The purpose of this funding opportunity is to develop artificial intelligence tools and experimental assays to identify new pharmacotherapeutics with lower toxicity and higher efficacy for substance… More | ||
| Harnessing Artificial Intelligence and Polypharmacology to Discover Pharmacotherapeutics for Substance Use Disorders (R41/R42 Clinical Trials Not Allowed) | RFA-DA-25-053 | NIDA | The purpose of this funding opportunity is to develop artificial intelligence tools and experimental assays to identify new pharmacotherapeutics with lower toxicity and higher efficacy for substance… More | ||
| Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed) | RFA-HD-25-009 | NICHD | The purpose of this Notice of Funding Opportunity (NOFO) is to address the needs of the maternal and pediatric HIV scientific community for research data translation and sharing. This initiative will… More | ||
| Single Source for the Continuation of the Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not Allowed) | RFA-TR-24-021 | NCATS | This is a non-competitive funding opportunity intended to fund a single award. NCATS is announcing its intent to issue a single source cooperative agreement to Cincinnati Childrens Hospital Medical… More | ||
| Adaptation of Diabetes Control Technologies for Older Adults with T1D (R01 Clinical Trial Optional) | RFA-DK-24-002 | NIDDK | The main objective of this NOFO is to foster development and testing of technologies adaptable to aging-related changes in older adults (aged 65 years or older) with T1D to improve diabetes… More | ||
| Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional) | RFA-DK-25-010 | NIDDK | This Notice of Funding Opportunity (NOFO) invites applications for Cystic Fibrosis (CF) Research and Translation Core Centers. CF Research and Translation Core Centers are designed to support both… More | ||
| Transformative Research on the Basic Mechanisms of Polysubstance use in Addiction (R01 - Clinical Trials Optional) | RFA-DA-25-043 | NIDA | This notice of funding opportunity (NOFO) will support projects proposing mechanistic studies that will transform our understanding of polysubstance use in addiction. These hypothesis-based,… More | ||
| Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed) | RFA-TR-22-030 | NCATS | The purpose of this funding opportunity announcement (FOA) is to solicit applications for pilot projects to elucidate a role for understudied proteins associated with rare diseases. Awards will… More | ||
| Research Program Award (R35 Clinical Trial Optional) | RFA-NS-22-038 | NINDS | The purpose of the NINDS Research Program Award (RPA) is to provide longer-term support, and increased freedom and flexibility, to Program Directors (PDs)/Principal Investigators (PIs), to allow them… More |